Regulatory Landscape Newsletter – March 2026

This is our Regulatory Landscape newsletter for March 2026 with our monthly insights on the evolving market for Regulatory professionals.   

For the month of February, there were 95 new Regulatory positions posted at smaller and mid-sized biopharma companies in the US. This is down 17% from January but up 15% from last February.  

48% of these new positions were in Clinical Regulatory Strategy and 26% were in CMC Regulatory, 11% in Regulatory Operations, and 14% were in Advertising, Promotions & Labeling. Roughly 67% of all new February Regulatory roles were at Director level and above.  There were 11 new Regulatory VP/SVP positions posted in February. 

48% of the new Regulatory positions in February were listed as Onsite, 25% were posted as Remote and 26% were Hybrid (remote and onsite).  33% of the February Regulatory positions were in California, 26% were in Massachusetts, and 25% were in the NJ/NY/PA area. 

There were layoffs announced at eight biopharma companies in February.

We are currently working on the following searches for our clients:


   –  Senior Vice President Regulatory Affairs – SF Bay Area
   –  Regulatory Affairs Director – SF Bay Area
   –  SVP of Regulatory, Quality, and Medical Writing – Remote/East Coast 
 
Please consider us for your Regulatory hiring or let us know if you are considering a career change soon.